Download full report with analyst certification and important disclosures
Dec 10 2024, 08:46 GMT
hVIVO
Positive contract win and reiteration of FY2024 guidance
- Sectors : Pharma and healthcare
- Companies : hVIVO
DAVY VIEW
hVIVO has announced that it has won a contract for £11.5m with an existing top-tier global pharma customer. This will involve a human challenge study to test the customer’s antiviral candidate. This is positive to see. hVIVO has also reiterated FY 2024 guidance on revenues and EBITDA margins.
